Phage Therapy for Multidrug-Resistant Bacterial Infections: Past and Future
top of page
Upcoming Seminars
N=1 Collaborative
Today, individualized medicines are possible.
We are on a mission to make them safe and rapidly accessible to patients worldwide.
Meet Hugh Hempel
We're thrilled to announce the appointment of N1C's new Executive Director
With a distinguished career in rare disease healthcare innovation, Hempel will be responsible for overseeing the growth of the organization, furthering its mission to advance global collaborations to develop a rigorous and accessible pathway for individualized medicines, and expanding access to therapies for rare disease patients.
Resources & Articles
bottom of page